//
Triple receptor agonist — mid-range concentration vial
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
The 20mg retatrutide vial supports extended or multi-arm research protocols investigating triple incretin receptor agonism. By engaging GLP-1, GIP, and glucagon receptors simultaneously, retatrutide enables study of complex receptor crosstalk in metabolic signaling networks.
Research with retatrutide explores the additive and synergistic contributions of GLP-1, GIP, and glucagon receptor co-activation to metabolic outcomes, energy regulation, and adipose signaling.
Price comparison based on publicly available data. Competitor prices may vary.
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
Use sterile water for injection. Allow to reach room temperature before reconstitution.
Stable for 24 months when stored properly. Once reconstituted, use within 30 days.